Last reviewed · How we verify
Programmed intermittent epidural bolus 10 ml
At a glance
| Generic name | Programmed intermittent epidural bolus 10 ml |
|---|---|
| Also known as | 10 mL |
| Sponsor | Ciusss de L'Est de l'Île de Montréal |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Pruritus
- Hypotension
- Fetal Heart Rate decelerations
- Nausea
- Postdural Puncture Headache
Key clinical trials
- Comparing PIEB and CEI for Labor Pain Relief (NA)
- PIB for Post-operative Analgesia After Laparotomy : Determining the Optimum Dose (NA)
- Drug Concentration and Volume on Adequate Labor Analgesia With PIEB (PHASE4)
- PIEB Compared With CEI on Breakthrough Pain in Nulliparous Women (NA)
- Programmed Intermittent Epidural Bolus Compared With Continuous Infusion in Multiparous Women (NA)
- Comparison of Safety and Efficacy Between PIEB and CEI for Labour Epidural Analgesia (PHASE4)
- Comparing Effectiveness of CSE Versus DPE for Labor Analgesia (PHASE4)
- Programmed Intermittent Epidural Bolus (PIEB) Techniques for Labour Analgesia (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: